Add to my selection

GAZYVARO

Medicine - Posted on Jul 01 2026

Active substance (DCI)

obinutuzumab

history (4)

5/20/26

GAZYVARO (obinutuzumab) - Glomérulonéphrite lupique (GNL)

L'essentiel Avis favorable au remboursement, en association avec le mycophénolate mofétil (MMF), pour le traitement des pati...

CAV :
54321

icône flèche
4/18/18

GAZYVARO (obinutuzumab)

GAZYVARO (obinutuzumab)

CAV :
54321

icône flèche
3/8/17

GAZYVARO (obinutuzumab), monoclonal antibody

No clinical benefit demonstrated in combination with bendamustine followed by Gazyvaro maintenance for the treatment of pati...

CAV :
54321

icône flèche
2/18/15

GAZYVARO (obinutuzumab), type II humanised anti-CD20 recombinant monoclonal antibody

Moderate improvement in the treatment of previously untreated chronic lymphocytic leukaemia in patients with comorbidities m...

CAV :
54321

icône flèche

Technical information

ATC code

L01FA03

Manufacturer

ROCHE SAS

Presentation

GAZYVARO 1000 mg, solution à diluer pour perfusion (code CIS : 61042996)
1 flacon(s) en verre de 40 ml (CIP : 34009 587 003 6 1)

All our publications

Autoimmune diseases

Hematologic cancers

Kidney diseases